Incident · Recall
FDA Class 2 recall of ReWalk Personal exoskeleton due to battery fire risk
ReWalk Robotics initiated a Class 2 device recall on February 28, 2020, after receiving two complaints (one in the US, one in Germany) alleging that the ReWalk device waistpack containing Li-Ion battery packs caught fire while being charged. The recall affected 350 units distributed nationwide in the US. The FDA determined the cause as device design. The recall was terminated on November 10, 2021.
Occurred 2020-02-28 · ReWalk Personal Exoskeleton at Multiple, USA · ReWalk Robotics · Multiple, USA · Exoskeletons · Investigated by FDA
How to read this record
Incident records on DEPLOY are compiled from public sources (regulatory filings, news reports, and operator disclosures) and reflect what has been reported and tracked to date. They are not legal findings, determinations of fault, or safety ratings, and may be updated as new information is verified. See the sources below for the underlying references.Machine-readable surfaces
- Markdown mirror: /incidents/rewalk-personal-battery-fire-recall-2020-02.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/incidents/272fb246-7955-4802-83c4-5d54b0871110
- Data documentation: /data
- Query this programmatically: Deploy MCP
Sources (1)
- FDA · https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRes/res.cfm?id=187111 · 2021-05-11
Status history
- Active · 2026-08-11 · agent:recon
Common questions
What happened in FDA Class 2 recall of ReWalk Personal exoskeleton due to battery fire risk?
When did this incident occur?
What robot was involved in FDA Class 2 recall of ReWalk Personal exoskeleton due to battery fire risk?
Has anyone responded to FDA Class 2 recall of ReWalk Personal exoskeleton due to battery fire risk?
What is the current status of FDA Class 2 recall of ReWalk Personal exoskeleton due to battery fire risk?
Methodology: Verified · 1 source (1 primary) · last reviewed 2026-08-23
Verification posture
Verified
High confidence
Review state
Stable
Last reviewed 2026-08-23
Sources by quality tier
- 1
- primary-fda-database
- FDA database
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for FDA Class 2 recall of ReWalk Personal exoskeleton due to battery fire risk.Deploy Watch
Track this incident.
We notify you when the regulator updates the record, the remedy status changes, or a related incident surfaces.
Canonical ID 272fb246-7955-4802-83c4-5d54b0871110